From Transvac initiative
TRANSVAC is dedicated to accelerate vaccine candidates across the R&D pipeline, by offering services to vaccine developers in academic and industry settings.
TRANSVAC services cover all aspects of vaccine development, for any target disease, for prophylactic, therapeutic, human and veterinary vaccines:
?Cross-platform screening and optimisation
? Analytical Services
? Adjuvants and delivery systems
⚗ Pre-clinical GLP Production Services
? GMP Production Services (Paid)
⚛ Structural Biology
? Immunocorrelates and Systems Biology
? Animal Models
? Clinical Trial support
COVID-19 vaccine development
Researchers developing vaccine candidates against COVID19 can also benefit from TRANSVAC2 services, namely but not exclusively:
Animal models
- CEA
- BPRC
- IRTA
- CReSA Centre de Recerca en Sanitat Animal and Helmholtz Centre for Infection Research (HZI)
Adjuvant formulation
- VACCINE FORMULATION INSTITUTE LIMITED
- HZI
Clinical Trial Support
- ECRIN (European Clinical Research Infrastructure Network)
Regulatory support
- EATRIS and European Vaccine Initiative
You can visit www.transvac.org for more information.